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Psychosis is accompanied by severe attentional deficits, and impairments in
associational-memory processing and sensory information processing that are ascribed
to dysfunctions in prefrontal and hippocampal function. Disruptions of glutamatergic
signaling may underlie these alterations: Antagonism of the N-methyl-D-aspartate
receptor (NMDAR) results in similar molecular, cellular, cognitive and behavioral changes
in rodents and/or humans as those that occur in psychosis, raising the question as to
whether changes in glutamatergic transmission may be intrinsic to the pathophysiology
of the disease. In an animal model of psychosis that comprises treatment with the
irreversible NMDAR-antagonist, MK801, we explored the cellular mechanisms that may
underlie hippocampal dysfunction in psychosis. MK801-treatment resulted in a profound
loss of hippocampal LTP that was evident 4 weeks after treatment. Whereas neuronal
expression of the immediate early gene, Arc, was enhanced in the hippocampus by
spatial learning in controls, MK801-treated animals failed to show activity-dependent
increases in Arc expression. By contrast, a significant increase in basal Arc expression in
the absence of learning was evident compared to controls. Paired-pulse (PP) facilitation
was increased at the 40 ms interval indicating that NMDAR and/or fast GABAergic-
mediated neurotransmission was disrupted. In line with this, MK801-treatment resulted
in a significant decrease in GABA(A), and increase in GABA(B)-receptor-expression in
PFC, along with a significant increase of GABA(B)- and NMDAR-GluN2B expression
in the dentate gyrus. NMDAR-GluN1 or GluN2A subunit expression was unchanged.
These data suggest that in psychosis, deficits in hippocampus-dependent memory may
be caused by a loss of hippocampal LTP that arises through enhanced hippocampal
neuronal excitability, altered GluN2B and GABA receptor expression and an uncoupling
of the hippocampus-prefrontal cortex circuitry.
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Introduction
Changes in neurotransmission, mediated by the glutamatergic, dopaminergic and GABAergic
systems may underlie pathophysiological changes in the brain that lead to psychosis (Laruelle
et al., 1996; Kristiansen et al., 2006; Abi-Dargham et al., 2012; Stan and Lewis, 2012). However,
dopamine receptor ligands treat only a subset of the symptoms (Chue and Lalonde, 2014),
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and pharmacological treatment to regulate neurotransmission
through GABA(A) receptors, fails to ameliorate symptoms
(Dold et al., 2013). In psychosis, hypofunction of glutamatergic
N-methyl-D-aspartate receptors (NMDAR) is believed to occur
(Gunduz-Bruce, 2009). Furthermore, NMDAR-antagonists
trigger psychotic episodes in healthy adults and exacerbate
symptoms in psychosis patients (Lahti et al., 2001). An
interplay with the dopaminergic and GABAergic systems is
likely (Healy and Meador-Woodruff, 1996; Cochran et al.,
2003; Hashimoto et al., 2003; Kinney et al., 2006). Moreover,
a reciprocal regulation of NMDAR and GABA-receptor
function may lie at the core of psychosis (Gordon, 2010;
Wiescholleck and Manahan-Vaughan, 2013a) and mediate
dopaminergic dysfunction in the disease (Schwartz et al.,
2012).
Early clinical intervention in psychosis greatly increases
the chances of improved clinical outcome (Álvarez-Jiménez
et al., 2012). Thus, an understanding of the mechanisms
that accompany the early stages of the disease is key to the
development of effective therapeutic strategies. Notwithstanding
their limitations, animal models of NMDAR-hypofunction
emulate many of the symptoms of psychosis seen in humans
(Neill et al., 2010; Wiescholleck and Manahan-Vaughan,
2013a). Prolonged treatment of rats with the irreversible
NMDAR-antagonist, MK801, emulates the chronic and
advanced phase of psychosis (Wiescholleck and Manahan-
Vaughan, 2013a). Furthermore, following acute, one-off
systemic treatment, animals exhibit symptoms of first-episode
psychosis (Wöhrl et al., 2007; Manahan-Vaughan et al., 2008a,b),
but also show long-lasting cognitive deficits (Manahan-
Vaughan et al., 2008a,b; Wiescholleck and Manahan-Vaughan,
2012, 2013b; Galizio et al., 2013; Lobellova et al., 2013).
These changes emulate deficits in hippocampus-dependent
memory, behavioral flexibility, attention, and working memory
that are known to occur in psychosis patients (Rajji et al.,
2009).
Hippocampal synaptic plasticity may underlie information
storage (Kemp and Manahan-Vaughan, 2007), and cognitive
processes such as the learning of spatial scenes, or contextual
fear memory are tightly associated with LTP (Straube et al.,
2003;Whitlock et al., 2006; Kemp andManahan-Vaughan, 2007).
LTP-like plasticity and learning are deficient in schizophrenic
patients after transcranial magnetic, or direct current stimulation
(Frantseva et al., 2008; Hasan et al., 2011), whereby both induce
synaptic plasticity in the cortex of healthy adults (Stefan et al.,
2000; Liebetanz et al., 2002). Strikingly, in close parallel to
these observations in humans, a profound loss of hippocampal
LTP that is persistent (>months), and is accompanied by
a significant loss of hippocampus-dependent memory occurs
in the MK801-animal model of psychosis (Manahan-Vaughan
et al., 2008a,b; Wiescholleck and Manahan-Vaughan, 2012,
2013b). This suggests that the hippocampus may be at the
center of cognitive changes that occur in psychosis and
raises the question as to the mechanisms that underlie these
alterations.
NMDAR-hypofunction reduces inhibitory GABAergic
neurotransmission (Schwartz et al., 2012). We postulated that
the loss of LTP and associated changes in memory function seen
in humans and rodents could arise from changes in glutamatergic
neurotransmission and increased neuronal excitability in the
hippocampus. To clarify this, we examined the mechanisms that
underlie LTP impairments and loss of hippocampus-dependent
memory (Manahan-Vaughan et al., 2008a,b; Wiescholleck
and Manahan-Vaughan, 2012, 2013b) that occur following an
acute systemic treatment with the NMDAR-antagonist, MK801
(Wiescholleck and Manahan-Vaughan, 2013a). We observed
that a chronic elevation in neuronal excitability occurred in
the hippocampus that was accompanied by a disruption of
inhibitory control in the prefrontal cortex. These changes
were mediated by alterations in expression of the NMDAR
subunit GluN2B in the hippocampus, along with changes in
GABA(A) and GABA(B) expression in both the hippocampus
and prefrontal cortex. We propose that in psychosis, deficits
in hippocampus-dependent memory are caused by a loss of
hippocampal LTP that arises through enhanced hippocampal
neuronal excitability, altered glutamate and GABA receptor
expression, and an uncoupling of the hippocampus-prefrontal
cortex circuitry.
Materials and Methods
Animals
The present study was carried out in accordance with the
European Communities Council Directive of September 22nd
2010 (2010/63/EEC) for care of laboratory animals and after
approval of the local government ethics committee (Bezirksamt,
Arnsberg). Male Wistar rats (7–8 weeks, Charles River,
Germany) were housed individually in a temperature- and
humidity-controlled vivarium with a constant 12-h light-dark
cycle (lights on from 6 a.m. to 6 p.m.) with ad libitum food
and water access. All surgical procedures and experiments were
conducted during the day.
Compounds and Drug Treatment
The NMDAR antagonist [+]-5-methyl-10, 11-dihydro-5H-
dibenzo-[a, d]-cyclohepten-5, 10-imine maleate (MK801, Tocris,
Germany) was dissolved in 0.9% physiological saline. MK801 (5
mg/kg) or vehicle (10ml/kg) were injected intraperitoneally (i.p.)
7 days before commencement of experiments. The concentration
of MK801 was chosen in accordance with previous studies
conducted by our group (Wöhrl et al., 2007; Manahan-Vaughan
et al., 2008a,b), in which the same dose proved to be effective
in inducing long-lasting effects. A single high-dose treatment,
as opposed to chronic low-dose treatment, was chosen in order
to specifically emulate the very first acute psychosis-related
experience (Wiescholleck and Manahan-Vaughan, 2013a).
Directly after injection, psychosis-like behaviors (locomotion,
ataxia and stereotypy) were observed. Twenty-four hours after
treatment the animals’ behavior was not different from vehicle
injected controls, as described previously (Wöhrl et al., 2007). No
differences in locomotion ability, grooming or rearing behavior
was observed over multiple days after treatment, in line with our
previous findings (Manahan-Vaughan et al., 2008a).
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Electrophysiology Procedures
Surgical Implantations
Animals were anesthetized (52 mg/kg pentobarbital via
intraperitoneal injection, i.p.) and underwent chronic
implantation of electrodes as described previously (Wiescholleck
and Manahan-Vaughan, 2013b). Specifically, a monopolar
recording electrode (1 mm diameter, 3.1 mm posterior to
bregma, 1.9 mm lateral to the midline) was placed in the
dentate gyrus granule cell layer and a bipolar stimulating
electrode was placed in the medial perforant pathway (1 mm
diameter, 6.9 mm posterior to bregma, 4.1 mm lateral to the
midline). The animals were allowed between 7 and 10 days
to recover from surgery before experiments were conducted.
Pre- and post-operative analgesia was implemented using
meloxicam (0.2 mg/kg, i.p.) and local administration of
xylocaine.
Responses were evoked in freely behaving animals by
stimulating at low frequency (0.025 Hz, 0.2 ms stimulus duration,
10,000 Hz sample rate). For each time-point, five evoked
responses were averaged. Dentate gyrus population spike (PS)
amplitude, as well as field excitatory postsynaptic potential
(fEPSP) slope were monitored. Each experiment started with
an input-output (i/o) curve (maximal stimulation 900 µA) to
determine the stimulus intensity required to elicit a PS that was
of 40% of the maximum obtained in the i/o curve. The i/o-curves
between vehicle- and MK801-treated animals did not differ at
any time-point after treatment. To ensure stability of recordings
and to assess basal synaptic transmission, all animals were tested
in a baseline experiment first, where only test-pulse stimulation
was applied.
LTP was induced by high-frequency stimulation (HFS) (10
bursts of 15 pulses at 200 Hz with 10 s interburst interval) and
was recorded 1 week before (pretreatment LTP control) and 4
weeks after MK801- or vehicle-treatment. PS and fEPSP values
for pretreatment LTP did not differ significantly in between the
two experimental groups. Short-term potentiation (STP) was
induced by weak HFS (wHFS, 3 bursts of 15 pulses at 200 Hz
with 10 s interburst interval).
Paired-pulse (PP) measurements, as a tool for assessment of
general excitability and neurotransmission, were performed by
PP stimulation every 40 s with interpulse intervals (IPI) of 20, 25,
40, 50, 100, 300, 500 ms and 1 s. The whole protocol was applied
3 times with an interval of at least 20 min.
At the beginning of each experiment, baseline evoked
potentials were assessed by averaging the response to stimulation
(five sweeps at 40 s intervals), every 5 min over a period of
60 min. At this point, either HFS or wHFS was given, and three
additional measurements at 5 min intervals were taken, followed
by recordings at 15 min intervals for 24 h.
Histology
At the end of the electrophysiological study, brains were
removed and histological verification of electrodes and cannula
localization was carried out, as described previously (Goh and
Manahan-Vaughan, 2013). Brain sections (16 µm) were stained
according to the Nissl method using 1% toluidine blue and then
examined using a light microscope. Data from animals, in which
an incorrect electrode or cannula localization was found, were
excluded from analysis.
Compartment Analysis of Temporal Activity by
Fluorescence in situ Hybridization
We examined Arc mRNA expression in rats that received a
systemic MK801 injection 4 weeks previously, compared to the
Arc mRNA expression in rats that received a systemic vehicle
injection. In a separate study, we analyzed Arc mRNA expression
that is triggered by novel holeboard learning in rats that were
treated with vehicle or MK801. Testing was conducted in a
gray perspex box (40 × 40 × 50 cm) that contained a hole
(5.5 cm diameter and 4.5 cm deep) in the floor of each corner
of the box (Kemp and Manahan-Vaughan, 2008a). Typically,
novel exploration of a novel empty holeboard facilitates LTP that
lasts for at least 24 h in rats (Kemp and Manahan-Vaughan,
2008a), and is prevented by pharmacological antagonists that
interfere with LTP (Kemp and Manahan-Vaughan, 2008b;
Lemon and Manahan-Vaughan, 2012). Holeboard learning in
the absence of afferent stimulation, is also impaired by the
same antagonists (Hagena and Manahan-Vaughan, 2012). All
animals were handled for 2 days before experiments. The rats
participated in the following behavioral protocol: One day before
the experiment, they were habituated for 1 h to a recording
chamber. On the experimental day, they were acclimatized to the
same chamber again for at least 60 min. Following this, the empty
holeboard was inserted. After 6 min of exploration time, starting
after the first direct hole exploration, brains were removed. The
exploration time of each hole was counted separately.
On each experiment day, the holeboard experiments were
performed for the same number of vehicle and MK801 injected
rats. However, the animals that did not perform holeboard
exploration were sacrificed on a different day than the rats
that performed holeboard exploration. Thus, no direct statistical
comparison between these two groups (Arc expression in the
absence of learning vs. Arc expression following learning) was
conducted.
After extraction, the brains were quick-frozen and stored at
−80◦C. The unfixed brains were cut coronally 20 µm thick on a
Cryostat (Leica CM 3050S) at approximately −20◦C, mounted
directly on superfrost plus slides (Gerhard Menzel GmbH,
Braunschweig, Germany) and stored at −80◦C until further
processing.
Compartment analysis of temporal activity by fluorescence
in situ hybridization (catFISH) was conducted by adapting the
procedure used by Guzowski andWorley (2001). The Arc cDNA
was produced by Entelechon (Bad Abbach, Germany) according
to the sequence of Lyford et al. (1995). Using the linearized
DNA, the antisense RNA probe labeled with fluorescein at
the uridine-5’-triphosphate site was created using the in vitro
transcription kit Ambion MaxiScript Kit (Invitrogen, Carlsberg,
USA). The length of the RNA probe was monitored by gel
electrophoresis.
Following fixation with 4% paraformaldehyde (PFA), brain
slices were deposited in a solution of acetic anhydride (Acros
Organics, New Jersey, USA) with diethylpyrocarbonate water
(C. Roth, Karlsruhe, Germany) and triethanolamine followed
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by an acetone/methanol (1:1) solution for 5 min. Afterwards,
the slides were set in a humid chamber that was prepared
with a 50% deionized formamide solution (Sigma-Aldrich,
St.Louis, USA). After covering with 1×-prehybridization buffer
(Sigma-Aldrich, St.Louis, USA), they were incubated for
30 min.
For the hybridization step, for each glass slide 1 ng mRNA
probe was dissolved in 1 µg 1×-hybridization buffer (Sigma-
Aldrich, St.Louis, USA), heated at 90◦C for 5 min and placed
directly on ice. The slices were incubated with the Arc mRNA
in a humidity chamber at 56◦C overnight. Then, 10 µg/ml
ribonuclease A (from bovine pancreas, Sigma-Aldrich) was
added for 15 min at 37◦C. To block endogenous peroxidase,
the slices were pretreated with 3% H2O2 for 15 min, and in
order to inhibit unspecific binding of proteins, a solution of
10% normal goat serum (n-Goat) was added for 60 min in the
humid chamber. Anti-fluorescein-peroxidase (polyclonal sheep
Fab-fragment, 11426346910, Roche Diagnostics, Mannheim,
Germany) was applied in a dilution of 1:400 in 1% n-Goat for
2 h. After washing 3 times 5 min with tris-buffered saline (TBS)-
Tween 20 (Polysorbate 20), a solution of biotinylated tyramine
(bT), H2O2 (0.02%), and TBS was applied (1:1:100) for 30 min to
enhance the fluorescence signal. Then, the slices were incubated
in a dilution of StrepAvidin Cy5 (Dianova, Hamburg, Germany)
1:3000 with 1% bovine serum albumin (BSA, Sigma Aldrich,
St. Louis, USA) in TBS-Tween for 30 min. In order to label
the nuclei of the cells, 4’, 6-diamidino-2-phenylindole (DAPI,
Invitrogen, Carlsberg, USA) was added in a concentration of
1:10000.
For glutamic acid decarboxylase 2 (GAD67) staining,
the slices were incubated in 10% n-Goat and 0.2% Triton
X (Tx, Sigma Aldrich, St. Louis, USA) for 90 min on the
next day. Afterwards, they were treated with the GAD67
antibody (AB) (1:100, monoclonal mouse AB, MAB-5406,
Merck Millipore, Billerica, USA) and 1% n-Goat and 0.2%
overnight. On the next day, the slices were incubated
with Dylight-488 (1:250, Cy2-labeled goat-anti-mouse
AB, 115-485-166, Dianova) and 1% n-Goat and 0.2% Tx
and coverslipped with Vectorshield HardSet mounting
medium for fluorescence (Vector Laboratories, Burlingame,
USA).
As a dilution medium, saline-sodium citrate buffer were used
until the anti-fluorescein step, followed by TBS. DAPI and the
following procedures were conducted with phosphate buffered
saline (PBS) as the dilution medium.
Immunohistochemistry
All animals were handled for 2 days before experiments.
To arrest further brain degradation processes, the rats
were perfused with 4% PFA and the extracted brains were
stored and cryoprotected in PFA followed by sucrose (30%)
for 5 days at 4◦C. Serial coronal sections (30 µm thick)
were prepared using a freezing microtome. To minimize
errors, or variations in the processing of data sets, slices
from vehicle and MK801-treated animals were processed
together.
In order to reduce unspecific background staining,
endogenous peroxidase was blocked by 0.3% H2O2 and
then, endogenous biotin and electrostatic loadings of proteins
were reduced by 20% avidin (Avidin-biotin blocking kit, Vector
Laboratories, Burlingame, USA). Afterwards, the primary
antibodies (AB) were applied in 20% biotin (Avidin-biotin
blocking kit) overnight in their corresponding concentration:
GABA(A) (1:400, monoclonal mouse AB, MAB341, Merck
Millipore, Billerica, USA), GABA(B) (1:500, monoclonal
mouse AB, ab55051, Abcam, Cambridge, UK), GluN1 (1:400,
monoclonal mouse AB, 556308, PharMingen, Becton, Dickinson
and Company, Franklin Lakes, USA). GluN2A (1:750, polyclonal
rabbit AB, sc-9056, Santa Cruz Biotechnology, Santa Cruz,
USA), and GluN2B (1:200, polyclonal goat AB, sc-1469, Santa
Cruz Biotechnology, Santa Cruz, USA), The secondary AB,
rat-absorbed biotinylated horse-anti-mouse (BA-2001), goat-
anti-rat (BA-1000), and horse-anti-goat antibodies (BA-9500)
(all from Vector Laboratories, Burlingame, USA), were added
1:500 for 90 min. After applying the ABC-Elite detection system
1:1000 for 90 min, the reaction was visualized by incubation in
0.05% 3, 3’-Diaminobenzidine-solution (DAB, Sigma-Aldrich,
St.Louis, USA) and 0.01% H2O2 for 10 min.
For staining of GABA(A), GABA(B) and GluN2B the dilution
medium contained 10% normal serum (Vector Laboratories,
Burlingame, USA) diluted in PBS containing Tx. For staining of
GluN1 and GluN2A, 1% BSA in TBS containing Tx was used as
the dilution medium.
To enhance the staining of GluN1 and GluN2A, the sections
were left in the primary AB solutions for 5 days at 4◦C. Following
the secondary AB, the sections were enhanced with bT as
described by Adams (1992). After mounting on gelatinized slides
and dehydration, they were cover-slipped with DePeX (Serva,
Heidelberg, Germany).
To verify antibody specificity, we conducted western blotting
of GABA(A), GABA(B) and GluN1 receptors, and used
an immunoprecipitation approach to assess GluN2A and
GluN2B (Burry, 2000; Figure 1). Hippocampal tissue from
6–8 week old male Wistar rats was used. Hippocampi were
homogenized at 4◦C in Tris-HCI buffer (20 mM, pH 7.4)
containing 10% sucrose. Homogenates were centrifuged at
4◦C for 30 min with 14,000 g. Pellets were resuspended
in ice-cold Tris-HCl buffer, pH 7.4 that contained cocktail
of protease inhibitors (Sample buffer). The total protein
concentration of each sample was determined using a Bradford
protein assay.
For western blot experiments, 20 µg protein was applied
to each gel. Gel electrophoresis was conducted using 8%
sodium dodecyl sulfate (SDS) polyacrylamide gels run on a
mini-gel apparatus (Pequlab), for 1.5 h at room temperature.
The western blot transfer was conducted in cold transfer
buffer (wet conditions) using a western blot transfer system
(Consort) at 400 V, 250 mA for 1.5 h. Membranes were
incubated for 1 h in TBS buffer (100 mM Tris-HCl; 0.9%
NaCl, 1% Tween 20, pH 7.4) containing 5% non-fat dry milk
to block nonspecific binding sites. Blots were subsequently
incubated overnight at 4◦C with antibodies that labeled GluN1
(1:750 dilution), Glun2A (1:250 dilution), GluN2B (1:500
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FIGURE 1 | Verification of antibody specificity. (A–C) Examples of
western blots showing binding specificity of the antibodies used in the
immunohistochemistry experiments: the GABA(A) antibody labeled a band
of ca. 50 kDa (A) corresponding to the target receptor (Olsen and Tobin,
1990). Two bands were labeled by the GABA(B) receptor antibody (B),
that correspond to the GABA(B) receptor subtypes 1 and 2 (Kaupmann
et al., 1998). The GluN1 antibody (C) labeled a ca. 120 kDa band,
corresponding to the reported kDa weight of GluN1 (Riou et al., 2012).
β-actin (42 kDa) was used as a protein-loading control. Hippocampal
tissue was used for assessment. Each lane corresponds to a separate
sample. (D,E) Examples of immunoblots showing binding specificity of
GluN2A (D) and GluN2B (E). The GluN2A and GluN2B antibodies labeled
ca. 177 and ca. 178 kDa bands, respectively. These bands correspond
to the reported kDa weights of the target receptors (Riou et al., 2012).
Hippocampal tissue was used for assessment. Each lane corresponds to
a separate sample.
dilution), GABA(A) (1:500 dilution), or GABA(B) (1:500
dilution). As a loading control, we used β-actin that was
labeled using a monoclonal antibody (1:20000 Sigma, St.
Louis, USA).
For immunoprecipitation experiments, a total of 200 µg
of protein of tissue lysate was filled up to 400 µl of total
volume with sample buffer and incubated with either anti-
GluN2A or anti-GluN2B antibody. Immunocomplexes were
captured by incubating overnight with protein A Sepharose
beads at 4◦C. Beads were washed three times in Sample buffer.
Immunoprecipitated proteins were eluted with Laemmli buffer
2x and immunoblotted using the indicated primary antibodies
(1:250 dilution).
For both western blots and immunoblots, immunoreactivity
was revealed using HRP-coupled anti-rabbit or anti-goat
secondary antibodies (1:10,000 dilution, GE Healthcare,
Freiburg, Germany) and the enhanced ECL detection system
(GE Healthcare, Freiburg, Germany). Quantification was done
by densitometric analysis using the programs ScanJet (Hewlett
Packard, Palo Alto, USA) and ImageJ 1.45S (Wayne Rasband,
National Institutes of Health, USA, Java 1.6.0_20 (64 bit)). The
lanes in Figure 1 correspond to separate hippocampal samples.
Brain Slice Assessment
For both the in situ hybridization and immunohistochemistry,
hippocampal brain areas were assessed at approximately
−3.3 mm and −4.3 mm relative to bregma (Figure 2).
For the in situ hybridization, we analyzed representative
and randomly chosen small areas of the DG, the CA3
and the CA1 region. For the immunohistochemistry,
we analyzed the whole area of the DG, the CA4, the
CA2/3 region and the CA1 region. Additionally, for the
immunohistochemistry, prefrontal areas at approximately
3.2 mm and 2.2 mm relative to bregma were used,
corresponding to the medial prefrontal cortex. For both
techniques, Nissl staining using 1% toluidine blue was
made for surveillance of quality and spatial orientation. In
addition, negative controls were prepared for supervision
of specificity. For this purpose each primary antibody and
each secondary antibody was used separately following the
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FIGURE 2 | Schema of the areas analyzed in the prefrontal cortex
and hippocampus of the rat. Nissl stained sections of the prefrontal
cortex (PFC) (A) and hippocampus (C) that correspond to the analysed
areas of the medial PFC (B) and dorsal hippocampus (D) that were
assessed in the present study. Figure 1B is based on Paxinos and
Watson (1986).
staining protocols. No staining could be observed in these
negative controls, indicating that the staining observed was
specific.
To analyze the amount of receptor expression, we either
counted the cells per mm2 or we measured the optical
density within the subregions of the hippocampus using
the software ImageJ (densitometry of the DAB-labeled
immunohistochemistry). To correct for differences in the
optical density, we subtracted the optical density measured
for background staining (within the corpus callosum) from
the optical density measured within the subregions of the
hippocampus, for each individual slice. This was done to address
differences in staining intensity between sections.
Data Analysis and Statistics
In all electrophysiological experiments, data were expressed
as mean % pre-injection values ± standard error of the
mean. A mixed ANOVA with the repeated measures factor
(TIME) and between-groups factor (GROUP) was used to
evaluate differences in plasticity between control experiments
and experiments after MK801, or vehicle application.
In the catFISH experiments, MK801 and vehicle-injected
groups were compared. For each animal, we labeled three
consecutive slices, and z-stacks were obtained from the CA1, CA3
and DG region of one hemisphere of each slice using a Zeiss
ApoTome (63× magnification). Only cells were included where
the entire nucleus was visible in the z-stack. The percentage
of intranuclear Arc-positive cells within the hippocampal
regions was analyzed. All GAD67-positive interneurons and
glial cells were excluded from the analysis. To control for bias,
measurements were carried out blind and additionally spot-
checked by two additional individuals. A multifactorial one-way
ANOVA using a between-group factor TREATMENT (vehicle
vs. MK801) and a between-group factor REGION (PFC, DG,
CA4, CA2/3 and CA1 for immunohistochemistry; DG, CA3
and CA1 for in situ hybridization) was used to analyze the
immunohistochemistry or catFISH data. The catFISH data was
furthermore separated according to the behavioral protocol
(without holeboard exploration or after holeboard exploration).
All data were shown asmean± standard error ofmean. Statistical
analysis was performed using the SPSS software (version 19). The
level of significance was set at p< 0.05.
Results
Hippocampal LTP in Behaving Rats is Impaired
after MK801-Treatment
In line with previous reports (Manahan-Vaughan et al., 2008a,b;
Wiescholleck and Manahan-Vaughan, 2012, 2013b), LTP that
was induced by HFS (200 Hz) was significantly impaired in
MK801-treated animals 1 and 4 weeks after treatment, compared
to animals that received vehicle F(1,6) = 36.351, p < 0.005, n = 4,
Figure 3). Control animals expressed robust LTP that lasted
for over 24 h, whereas MK801-animals showed an immediate
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FIGURE 3 | Electrophysiological responses following
MK801-treatment. (A) MK801-treatment impairs LTP. High frequency
stimulation (HFS) elicits robust LTP that persists for over 24 h in animals that
were treated 1 week (A), or 4 weeks (B) previously with vehicle. In contrast,
LTP is profoundly impaired 1 (A), or 4 weeks (B) after MK801-treatment.
Insets: Analogs (control—dashed line, MK801—black line) were obtained 1,
pre-HFS, 2, 5 min post-HFS and 3, 24 h post-HFS. Vertical scale-bar
corresponds to 5 mV, horizontal scale-bar to 10 ms. *p < 0.05. (C)
Paired-pulse (PP) responses are facilitated at the 40 ms interval after
MK801-treatment. The graph shows PP responses at the interpulse intervals
(IPI) of 20, 25, 40, 50, 100, 300, 500 ms and 1 s. The PP ratio was
determined by dividing the amplitude of the second population spike (PS) in
mV divided by the amplitude of the first PS (PS2/PS1). PP facilitation was
evident at the 40 ms IPI after a single MK801-injection. Responses were
unaffected at all other IPIs. *p < 0.05.
impairment of LTP after HFS. This suggests that a single
treatment with MK801 is sufficient to cause prolonged effects on
hippocampal function. In line with this, we have observed that
hippocampus-dependent learning is also chronically impaired
(Manahan-Vaughan et al., 2008a,b; Wiescholleck and Manahan-
Vaughan, 2012, 2013b).
Neuronal Arc Expression is Enhanced in the
Hippocampus Following Spatial Learning in
Vehicle-Treated Rats. MK801-Treatment
Increases Basal Arc Gene Expression in the
Hippocampus, but does not Increase Arc
Expression after Spatial Learning
The immediate early gene, Arc, is a very useful marker for
activity-dependent neuronal activity. Arc gene transcription is
rapidly induced by synaptic activity and precipitates in neuronal
dendrites of non-GABAergic recently activated neurons (Link
et al., 1995; Lyford et al., 1995). Furthermore, Arc is linked to
learning and behavior, NMDAR-LTP, homeostatic scaling and
structural plasticity (Korb and Finkbeiner, 2011). We therefore
used compartment analysis of temporal activity by fluorescence
in situ hybridization (catFISH) of Arc (Guzowski et al., 1999)
to examine whether experience-dependent neuronal activity is
altered following learning in the MK801-model.
We first assessed basal Arc gene expression in MK801-treated
animals compared to vehicle-injected controls (Figures 4A–C,
5). A multifactorial ANOVA showed, for the group without
holeboard exploration, an effect for the factor TREATMENT
(F(1,24) = 20.61, p< 0.001) and the factor REGION (F(2,24) = 4.69,
p < 0.05). No interaction effect TREATMENT ∗ REGION was
observed (F(2,24) = 0.15, p = 0.86). The post hoc test showed that
4 weeks after injection, MK801-treated animals (n = 5) exhibited
significantly higher basal Arc expression in the CA1 region (p
< 0.01, Figure 4A), the CA3 region (p < 0.03, Figure 4B) and
the dentate gyrus (p < 0.05, Figure 4C) in the MK801-treated
animals compared to vehicle-injected controls (n = 5). These
findings suggest that hippocampal neurons of MK801-treated
animals have lower excitability thresholds and may engage in
redundant information encoding. Psychosis is characterized by
an excessive processing of irrelevant stimuli as well as memory
deficits (Anticevic and Corlett, 2012). We therefore asked the
question if a learning event, that is known to promote the
expression of LTP and result in long-term memory (Kemp and
Manahan-Vaughan, 2004) results in increased Arc expression in
MK801-animals.
We exposed the animals to a novel holeboard and then
examined Arc-related expression in hippocampal neurons.
After spatial learning the MK801 treatment did not result in
increased Arc expression compared to vehicle injected animals
(Figures 4A–C, 5): A multifactorial ANOVA did not reveal an
effect for the factor TREATMENT (F(1,24) = 2.30, p = 0.14),
the factor REGION (F(2,24) = 0.16, p = 0.85) or the interaction
TREATMENT ∗ REGION (F(2,24) = 0.11, p = 0.90).
To rule out that the differences in basal Arc expression
observed can be explained by the behavior of the rats, we
compared the rats’ activity during exploration of the empty
holeboard. We measured the time that each rat spent exploring
the different holes, i.e., dipping their heads into one of the holes,
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FIGURE 4 | Overview of Arc expression in naïve animals or following
spatial learning. Bar charts summarize Arc expression in naïve animals that
were treated with vehicle or with MK801 4 weeks previously. In the CA1 region
(A), the CA3 region (B) and dentate gyrus (C), basal Arc expression is
significantly increased in MK801-treated animals compared to vehicle-injected
controls. In a separate animal cohort, novel spatial exploration resulted in
significant elevations of neuronal Arc expression in the hippocampus of
vehicle-treated animals compared to their naïve state. This was not the case for
MK801-treated animals. Here, no difference was detected in Arc gene
expression after novel spatial exploration. *p < 0.05, **p < 0.01.
FIGURE 5 | MK801-treatment alters basal Arc gene expression in the
hippocampus. Spatial learning elicits increases in Arc expression in control,
but not MK801-treated animals. The images show Arc expression (red dots) in
the CA1 and CA3 regions and dentate gyrus (DG), in naïve animals, after
vehicle (left images) or MK801 injection (right images). MK801-treated animals
exhibit a significantly higher basal Arc expression in the CA1 and CA3 regions
compared to vehicle-treated animals. The nuclei were stained in blue using
DAPI. The pictures were taken using a 63× objective.
within a 6 min period (not shown). The average exploration
time of vehicle-treated animals (n = 5) was 10.57 ± 1.9 s, and of
MK801-treated animals (n = 5) was 13.21 ± 1.9 s. No significant
difference was evident between the groups (t-test: p> 0.05).
These findings suggest that the aberrantly enhanced
expression of Arc in MK801-treated animals reflects intrinsic
elevations in neuronal excitability thresholds that impair signal-
to-noise ratios to such an extent, that a novel learning event
cannot be effectively encoded. To clarify this, we examined PP
responses.
Paired-Pulse Facilitation is Increased at the
40 ms Interval after MK801-Treatment
Neurotransmission was examined in control animals (n = 12)
and in animals treated with MK801 (n = 14), by stimulating the
perforant path with pulse pairs, of constant stimulus intensity,
at inter-pulse intervals of 20, 25, 40, 50, 100, 300, 500 and
1000 ms. We found that MK801-treated animals (n = 5) showed
a PP facilitation at the 40 ms interval compared to control rats
(F(1,24) = 5.156, p < 0.05, n = 5) Figure 3C). At all other inter-
pulse intervals, there were no differences in PP response between
control animals and those that were treated with MK801 prior
to testing (20 ms: F(1,24) = 0.940, n.s.; 25 ms: F(1,24) = 0.156, n.s.;
40 ms: F(1,24) = 5.156, p< 0.05; 50ms. F(1,24) = 0.734, n.s.; 100ms:
F(1,24) = 0.654, n.s.; 300 ms: F(1,24) = 0.816, n.s.; 500 ms: F(1,24) =
0.951, n.s.; 1000 ms: F(1,24) = 0.334, n.s).
This specific interval reflects neurotransmission mediated
by NMDAR and GABA(B) receptors, and suggests that
neurotransmission is enhanced at perforant path-dentate gyrus
synapses ofMK801-treated animals. Inhibitory tonus is regulated
by GABA(A) and GABA(B) receptors (Mann et al., 2009). Thus,
we explored whether expression of these receptors is altered after
MK801-treatment. Given its role in memory and its proposed
dysfunction in psychosis, we also examined expression in the
prefrontal cortex.
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GABA(A) Expression is Decreased in the
Prefrontal Cortex, whereas GABA(B) Expression
is Increased in Prefrontal Cortex and Dentate
Gyrus after MK801-Treatment
GABA(A) expression was significantly decreased 4 weeks after
MK801 treatment (n = 5) compared to vehicle-treated controls
(n = 5, Figures 6, 7) (multifactorial ANOVA: TREATMENT
F(1,40) = 14.92, p < 0.001, REGION F(4,40) = 80.48, p < 0.001).
Furthermore, a Duncan’s post hoc test revealed that the prefrontal
cortex was specifically affected (vehicle: 72.50± 1.47 vs. MK801:
61.07 ± 3.32; p < 0.01), whereas no significant changes were
evident in the hippocampal subfields (Figures 5, 6).
GABA(B) expression was significantly increased in MK801-
treated animals (n = 5) compared to controls (n = 5,
Figures 6, 7) (multifactorial ANOVA: TREATMENT F(1,40)
= 42.586, p < 0.001, REGION F(4,40) = 555.14, p < 0.001,
interaction TREATMENT×REGION F(4,40) = 20.33, p< 0.001).
In this case, the increases in expression occur in both the
prefrontal cortex (Duncan’s post hoc test, vehicle: 375.25 ± 14.6
vs. MK801: 542.5 ± 28.79, p < 0.001) and the dentate gyrus
(Duncan’s post hoc test, vehicle: 73.11 ± 3.49 vs. MK801: 118.37
± 9.99, p< 0.01) (Figures 6, 7).
These findings suggest that the alterations in neuronal
excitability, and dysfunctional information processing that we
detected in MK801-treated animals results from alterations
in GABA receptor expression in both the hippocampus and
prefrontal cortex.
GluN2B, but not GluN2A or GluN1 Expression is
Increased in the Dentate Gyrus 4 Weeks after
MK801 Treatment
With respect to the expression of the NMDAR subunits,
GluN1 and GluN2A, no statistically significant differences
between vehicle and MK801-treatment could be observed in
the prefrontal cortex or the different hippocampal subregions
4 weeks after treatment with either MK801 or vehicle
(multifactorial ANOVA, n.s., Figures 6, 7). However, GluN2B
expression was significantly increased (multifactorial ANOVA,
factor TREATMENT F(1,40) = 14.259, p< 0.001, factor REGION
F(4,40) = 13.55, p < 0.001, Figures 6, 7). These increases were
specific to the dentate gyrus (Duncan’s post hoc test, vehicle:
28.60± 2.11 vs. MK801: 38.13± 2.61, p< 0.01).
Discussion
The results of this study show that deficits in hippocampal
LTP in the MK801-animal-model of psychosis are associated
with elevations in neuronal excitability that are accompanied by
changes in GABA-receptor expression in the hippocampus and
prefrontal cortex, along with increased GluN2B-expression in
the dentate gyrus. We propose that neuronal hyperexcitability
in the hippocampus, coupled with an imbalance of GABAergic
inhibitory control in the prefrontal cortex, results in an
uncoupling of hippocampus-prefrontal cortex communication,
and comprises a key aspect of hippocampal and memory
dysfunction in psychosis.
Acute MK801-treatment results in transient behavioral
changes that emulate a psychotic episode (Wöhrl et al., 2007;
Manahan-Vaughan et al., 2008a). A severe LTP impairment
is triggered in the dentate gyrus, that doesn’t recover with
time (Wiescholleck and Manahan-Vaughan, 2013b). In the
present study, we observed that 4 weeks after MK801-treatment,
LTP was still impaired. There are two possible explanations
for this deficit: irreversible NMDAR-antagonism chronically
disables NMDAR-dependent LTP, or neuronal excitability
becomes persistently elevated, such that a further potentiation
of synaptic efficacy by LTP is no longer possible. In the dentate
gyrus, LTP is not exclusively NMDAR-dependent (Manahan-
Vaughan et al., 1998), thus perpetual NMDAR-knock-down
may not necessarily result in a complete failure of LTP.
In contrast, it has been demonstrated that pushing synaptic
potentiation to its upper limits by repeated afferent tetanisation,
not only disables the ability of the affected hippocampal
synapses to express LTP, but it also prevents new spatial
learning (Moser et al., 1998; Moser and Moser, 1999). Given
the fact that psychosis patients exhibit a loss of sensory
(Javitt, 2009) and sensorimotor gating (Braff et al., 1978)
and higher resting BOLD responses in multiple cortical areas
(Medoff et al., 2001), we postulated that excitability levels
may increase in the hippocampus following MK801-treatment,
and explored if activity-dependent neuronal activity becomes
altered.
Arc is expressed in an activity-dependent manner in response
to hippocampus-dependent learning (Guzowski et al., 1999).
It is transcribed at a low level under basal (naïve) conditions
(Guzowski et al., 2001; Korb and Finkbeiner, 2011). Strikingly,
we observed that basal Arc expression was significantly higher
in MK801-treated animals compared to controls. In other words,
neuronal activation is elevated in MK801-treated animals even in
the absence of hippocampus-dependent learning. This suggests
that the hippocampi of MK801-treated rats may be encoding
stimuli and experiences that would normally be dismissed as
irrelevant by healthy rats. This is an interesting possibility, as
it is known that psychotic patients exhibit excessive processing
of irrelevant stimuli that result on the one hand, in cognitive
misrepresentations, and on the other hand, in memory deficits
(Anticevic and Corlett, 2012). We therefore asked the question
if novel spatial learning, that is known to cause a transient
and activity-dependent elevation of Arc expression hippocampal
neurons, and strengthens LTP (Kemp and Manahan-Vaughan,
2007), can trigger additional Arc expression in MK801-treated
animals, that occurs in addition to the already enhanced Arc
expression. Strikingly MK801-animals failed to show an increase
compared to control animals after the same learning event. This
suggests that the elevated levels of basal Arc expression interfere
with the encoding of novel spatial experience. We postulate that
this aberrantly enhanced expression of Arc in MK801-treated
animals reflects intrinsic elevations in neuronal excitability
thresholds that impair signal-to-noise ratios to such an extent,
that a novel learning event cannot be effectively encoded.
In line with this, paired-pulse (PP) responses were enhanced
at the 40 ms interval. In the PP paradigm, two stimuli are
delivered with different intervals in the range of 20–1000 ms.
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FIGURE 6 | MK801-treatment alters GABA receptor and
N-methyl-D-aspartate receptor (NMDAR) subunit expression in the
hippocampus and prefrontal cortex. Bar charts represent receptor
expression in the hippocampal subregions (CA1, CA2/3, CA4, dentate
gyrus:DG), and in the prefrontal cortex (PFC) 4 weeks after
MK801-treatment (derived from densitometry of the DAB-labeled
immunohistochemistry). In MK801-treated animals, (A) GABA(A)
expression was reduced in the prefrontal cortex but unchanged in the
hippocampus, whereas GABA(B) expression (B) was significantly
increased in both the dentate gyrus and prefrontal cortex compared to
vehicle-treated controls. Whereas GluN1 (C) and GluN2A (D) expression
was unaffected by MK801-treatment, GluN2B expression (E) was
significantly increased in the dentate gyrus compared to vehicle-treated
controls *p < 0.05.
The population spike (PS), which reflects the number and
synchrony of granule cell discharges (Andersen et al., 1971),
exhibits a depression of the 2nd PS at PP-intervals of 20–40 ms,
followed by facilitation at PP-intervals of 40–200 ms, and
depression at longer intervals. At PP-intervals of 20–40 ms, the
PS-depression most likely occurs due to GABA(A)-activation,
which in turn leads to an increase in chloride conductance
(Albertson and Joy, 1987). At 40–200 ms stimulus intervals,
GABA(B)-autoreceptors are active, thereby inhibiting GABA
release. At the same time NMDAR are activated (McNaughton,
1982; Albertson and Joy, 1987). The enhanced facilitation
we saw at the 40 ms PP-interval may thus relate to a
disinhibition of principle cells. This could be triggered by
changes in expression of GABA(B) -receptors, or of NMDAR.
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FIGURE 7 | Photomicrographs of expression of GABA(A), GABA(B)
and GluN2B in the hippocampus and prefrontal cortex.
Photomicrographs show examples of receptor expression in the
hippocampus (left panels) and prefrontal cortex (PFC) (right panels)
4 weeks after MK801-treatment. In each case, the left panel for the
respective subregion shows the control examples. Examples for
GABA(A), GABA(B), and GluN2B are shown. Scale bar, hippocampus
1 mm, PFC 5 mm. The examples highlight the decrease of
GABA(A)-receptor expression in the prefrontal cortex, the increase of
GABA(B)-receptor expression in the dentate gyrus and prefrontal cortex
and the increase of GluN2B expression in the dentate gyrus 4
weeks after MK801-treatment.
To explore this we examined the expression and distribution
of GABA(A) and GABA(B)-receptors, as well as the GluN1,
GluN2A and GluN2B subunits of the NMDAR in the
hippocampus.
After MK801-treatment, GABA(B)-receptor and GluN2B
expression was enhanced in the dentate gyrus. The CA-subfields
of the hippocampus were unaffected. This suggests that increases
in neuronal excitability in the dentate gyrus underlie the
deficits in LTP we observed. It also explains why PP-responses
were increased at the 40 ms interval. GABA(B)-receptors
regulate basal inhibitory tonus (Mann et al., 2009), but in the
dentate gyrus, they play a very important role in stimulating
excitability of granule cells, by reducing synaptic inhibition
that is mediated by hilar interneurons (Burgard and Sarvey,
1991; Mott and Lewis, 1991; Mott et al., 1993). This serves to
promote transfer of incoming information from the entorhinal
cortex, via the perforant path, to the hippocampus. Thus, an
enhancement of GABA(B)-receptor expression in the dentate
gyrus may not only result in neuronal hyperexcitability, it
could also result in the processing of irrelevant information
by the hippocampus, due to a weakening of gate control
of entorhinal inputs. This alteration will be compounded by
the increase in GluN2B expression that was specific to the
dentate gyrus. GluN2B-containing NMDAR require intense
postsynaptic depolarization to remove the voltage-dependent
Mg2+-block of the NMDAR and result in channel opening
(Köhr et al., 2003; Erreger et al., 2005; Berberich et al.,
2007), but when activated, they support twice as much charge-
transfer (as GluN2A-containing NMDAR), deactivate slower
and support a greater Ca2+-influx per unit of current (Vicini
et al., 1998; Sobczyk et al., 2005). An increase in GluN2B-
expression will increase the ease with which incoming stimuli can
result in LTP, but if this occurs on a background of enhanced
neuronal excitability, it will not necessarily result in persistent
or appropriate long-term encoding (Moser and Moser, 1999).
Taken together, the enhanced expression of GABA(B)-receptors
and GluN2B comprise a highly potent partnership, that can
not only be expected to raise elevate neuronal excitability in
the dentate gyrus, but mediate redundant synaptic information
encoding, impaired LTP, and excessive encoding of experiences
that would normally be ignored by the hippocampus. The
alterations in dentate gyrus information processing can also be
expected to impair information processing in the CA-subfields
of the hippocampus (Bikbaev et al., 2008). In line with this,
activity-dependent Arc expression was elevated throughout the
hippocampus in MK801-treated animals, although increased
expression of GABA(B) and GluN2B was localized to the dentate
gyrus.
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Both hypoactivation and hyperactivation of the prefrontal
cortex may contribute to psychosis, and both, when mediated
by changes in GABAergic inhibition, lead to attentional deficits
(Pezze et al., 2014). Although it is unclear if NMDAR are
affected in the prefrontal cortex of psychotic patients (Akbarian
et al., 1996; Toro and Deakin, 2005), ketamine-induced psychosis
alters metabolic response in this structure (Breier et al., 1997).
Thus, we explored if GABA-receptors or GluN-subunits are
altered in the prefrontal cortex. Here, we saw no change in
GluN-subunits, whereas GABA(A) expression was decreased
and GABA(B) expression was increased. These changes can
be expected to cause a potent suppression of GABAergic
transmission in the prefrontal cortex. Whereas a reduction
in GABA(A)-expression under conditions of normal GABA
tonus would be expected to result in increased neuronal
excitability, the increase in GABA(B)-expression may counteract
this to some extent, because basal GABAergic tonus is
likely to be reduced (Mann et al., 2009). Nonetheless, it
is possible that localized neuronal excitability is increased
due to deficits in fast GABAergic transmission, mediated
by GABA(A) (Nicoll et al., 1990), leading to aberrant
information processing. The increased GABA(B)-expression
can be expected to have far-reaching effects. This receptor
is important for the modulation of network activity in
the prefrontal cortex (Wang et al., 2010), and for the
regulation of cortical upstates (Mann et al., 2009) that are
essential for the synchronization of long-range cortical activity
(Volgushev et al., 2006). Impairments in these processes can
be expected to result in attentional and working memory
deficits (Major and Tank, 2004), as occur in psychosis (Millan
et al., 2012). We propose that the changed expression of
GABA-receptors in the prefrontal cortex, could reflect an
uncoupling of hippocampus-prefrontal cortex communication:
the neuronal hyperexcitability within the hippocampus and
associated enhanced output to the prefrontal cortex, will be met
by decreased information processing and cortical informational
relay that compounds the deficits in hippocampus-dependent
long-term memory. These changes may be initiated in the
hippocampus: intraperitoneal infusion of MK801 results in an
acute enhancement of medial prefrontal cortex potentials that
are evoked by hippocampal stimulation (Blot et al., 2015). Thus,
alterations in neuronal excitability in the hippocampus may
result in adaptive processes in the prefrontal cortex that comprise
changed GABA-receptor expression and are aimed to return
hippocampus-mediated elevations in excitability back to normal
levels.
Conclusions
Increases in neuronal excitability in the hippocampus
of schizophrenics, as indicated by elevations in regional
cerebral blood flow, have been reported (Medoff et al., 2001).
Furthermore, hypomagnesaemia causes neuronal excitability
and leads to psychosis (Morris, 1992). Our data indicate that
neuronal hyperexcitabillty in the hippocampus, together with
a disruption of inhibitory control in the prefrontal cortex,
contribute to the loss of LTP and may comprise a mechanism
underlying impairments of learning that occur in this model of
first-episode psychosis.
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